期刊文献+

胃窦癌术中区域动脉灌注化疗后门静脉血、周围静脉血、腹腔渗液及癌组织中药物浓度的测定 被引量:4

5-Fu concentration in splanchnic and peripheral blood, peritoneal fluid and carcinoma tissues after intraoperative regional arterial perfusion chemotherapy in patients of gastric antrum cancer
原文传递
导出
摘要 目的 探讨胃窦癌术中区域动脉灌注化疗的作用.方法 本组32例胃窦癌患者术中经胃网膜右动脉灌注5-氟尿嘧啶(5-Fu,1000 mg/m2),用高效液相色谱法测定注药后2、5、10、20、30、60 min门静脉血、周围静脉血、腹腔渗液及切除癌组织中5-Fu的浓度.结果 于注药后2 min门静脉血及腹腔渗液即出现峰浓度,分别为(48.8±6.8)μg/ml及(75.3±30.7)μg/ml,于注药后30 min门静脉血的浓度为(19.2±2.0)μg/ml,于注药后60 min腹腔渗液的浓度为(17.3±7.4) μg/ml,均超过有效抑癌浓度(15 μg/ml);于注药后5 min周围静脉血出现峰浓度,为(5.4±2.0) μg/ml,此后逐渐降低;手术切下的癌组织的药物浓度为(80.5±20.1)Lg/ml.结论 胃窦癌术中区域动脉灌注化疗可以在短时间内使门静脉血及腹腔渗液达到较高的药物浓度且持续时间长,术后切下的癌组织药物浓度远较周围血为高,有利于预防术中癌细胞的扩散及术后癌复发. Objective To measure 5Fu concentration after intraoperative regional arterial perfusion chemotherapy in gastric antrum cancer patients.Method In this study,32 gastric antrum cancer patients intraoperatively received through right gastroepiploic artery intraarterial perfusion of 5-Fu (1000 mg/m2),and drug conentrations were measured in portal venous blood,peripheral venous blood,peritoneal fluid and in removed cancer tissues 2,5,10,20,30,60 minutes after infusion started by high performance liquid chromatography method.Result 5-Fu in portal vein blood and peritoneal fluid reached peak concentration after 2 minutes at (48.8 ±6.8) μg1/ml and (75.3 ±30.7) μg/ml,respectively.The drug concentration in portal venous blood was (19.2 ± 2.0) μg/ml at 30 minutes and that in peritoneal fluid was (17.3 ±7.4) μg/ml at 60 minutes,both were higher than that of the effective experimental tumor suppressing concentration (15 μg/ml).Peripheral venous blood concentration reached peak concentration of (5.4 ± 2.0) μg/ml at 5 minute.The drug concentration in removed cancer tissues was (80.5 ± 20.1) μg,/ml.Conclusions Regional intraarterial perfusion chemotherapeutics in gastric antrum cancer patients during operation immediately makes the concentration of chemotherapy rise in the portal vein blood and peritoneal fluid and in cancer tissues to a much higher level than that in peripheral blood.This helps kill cancer cells that fell out during the surgery.
出处 《中华普通外科杂志》 CSCD 北大核心 2013年第10期748-750,共3页 Chinese Journal of General Surgery
关键词 胃肿瘤 化学疗法 肿瘤 局部灌注 Stomach neoplasms Chemotherapy,cancer,regional perfusion
  • 相关文献

参考文献6

二级参考文献40

  • 1高登鹏,张霄成,石秀玲,宋金福,陈宏杰.胃癌术中术后局部化疗对癌细胞及患者预后的影响[J].现代中西医结合杂志,2005,14(19):2535-2537. 被引量:9
  • 2顾劲松,于海滨,赵明友.直肠上动脉插管注射美蓝染色在直肠癌根治术中的应用[J].局解手术学杂志,2006,15(2):78-79. 被引量:4
  • 3吴泽宇,詹文华,李靖华,何裕隆,汪建平,兰平,彭俊生,蔡世荣.淋巴结微转移检测对胃癌病理分期的影响[J].中华胃肠外科杂志,2006,9(3):217-220. 被引量:14
  • 4杨少辉,戴冬秋.肿瘤抑制基因甲基化与胃癌[J].中国普外基础与临床杂志,2006,13(5):614-616. 被引量:8
  • 5段红 张俊文 汤为学 等.5-氟脲嘧啶及丝裂霉素对人胃癌细胞SGC-7901及BGc-823的相互作用.中国病理生理杂志,2000,16(10):1058-1058.
  • 6Maurer C A, Bomer M, Buchler M W.Regional chemotherapy of gastric intestinal cancer [J]. Digestive Surgery, 1997,14(1):9-22.
  • 7Goishi H, Tanaka S, Haruma K, et al .Predictive value of Cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer[J]. Oncology Reports,2000,7(4):713-718.
  • 8Yoshikawa T, Tsuburaya A, Kobayashi O, et al.Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma[J]. Cancer Letters, 2000,153( 1-2):7-12.
  • 9Driessen A, Landuyt W,Pastorekova S,et al. Expression of carbonic anhydrase Ⅸ (CA Ⅸ ), a hypoxia-related protein, rather than vaseular-endothelial growth factor ( VEGF ), a pro-anglogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas[J]. Annals of surgery, 2006,243( 3 ):334-340.
  • 10Sethna K S,Sugarbaker P H. New prospects for the control of peritancal surface dissemination of gastric cancer using perioperative intraperitoneal chemotherapy[J]. Cancer Therapy, 2004,2(A):B79.

共引文献25

同被引文献39

  • 1仇晓霞,邬亦华,郭艳.护士对肿瘤化疗药物的防护现状与对策[J].护理管理杂志,2007,7(1):9-11. 被引量:32
  • 2Shitara K, Munakata, M, Muto O, et al. Oxaliplation plus 5 - fluorouracil/leucovorin(folfox) as salvage chemotherapy in patients with pr~t - teated colorectal cancer [ J ]. Japan J Cancer Chemotherapy,2007,34 : 1079 - 1084.
  • 3魏国,毕建威,申晓军.第八届全军普通外科专业委员会成立会议暨第十届全军普通外科专业学术会议[C].2010.
  • 4李琦军,李勇,宋振川.复方氟尿嘧啶多相脂质体术前腹腔灌注对胃癌的影响[C].第三届中国肿瘤学术大会教育论文集,2004.
  • 5Cheng M, He B, Wan T. 5-Fluorouracfl nanoparticles inhibit hepa- tocellular carcinoma via activation of the p53 pathway in the ortho- topic transplant mouse model. PLoS One, 2012, 7(10): e47115.
  • 6Yadunandam AK, Yoon jS, Seong YA. Prospective impact of 5-FU in the induction of endoplasmic reticulum stress, modulation of GRP78 expression and autophagy in Sk-Hepl cells. Int I Oncol, 2012, 41(3): 1036-1042.
  • 7Deng YH, Pu XX, Huang MJ. 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD 133-positive colon cancer stem-like cells. Chin J Cancer, 2012, 29(9): 810-815.
  • 8Ueno T, Endo S, Saito R. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells. Oncol Res, 2013, 21(3): 155-164.
  • 9王建才.结直肠癌术中腹腔植入缓释剂的临床研究.湘雅医院,2013.
  • 10黄展宝.氟尿嘧啶缓释剂对人结直肠癌裸鼠微血管密度的影响及促肿瘤凋亡的机制研究.桂林医学院,2013.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部